CD8+ Sézary syndrome with interleukin-22 production modulated by bacterial sepsis

British Journal of Dermatology

Volumn 168, Issue 4, 2013, Pages 881-883

  Shimauchi, T ^a   Sasada, K ^a   Kito, Y ^a   Mori, T ^b   Hata, M ^b   Fujiyama, T ^a   Ito, T ^a   Hirakawa, S ^a   Tokura, Y ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Numazu City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 22; LINEZOLID; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BLOOD EXAMINATION; CASE REPORT; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CIRCULATING TUMOR CELL; CLINICAL FEATURE; CYTOKINE PRODUCTION; DERMIS; DISEASE COURSE; EOSINOPHIL; EOSINOPHILIA; EPIDERMIS; ERYTHRODERMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LETTER; LEUKOCYTE; LYMPH NODE BIOPSY; LYMPHOCYTE; LYMPHOID CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; POIKILODERMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SEZARY SYNDROME;

CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNITY, INNATE; INTERLEUKINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; SEPSIS; SEZARY SYNDROME; SKIN NEOPLASMS; STAPHYLOCOCCAL INFECTIONS;

EID: 84875434120     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12051     Document Type: Letter

References (9)

1. Duvic M, Hester JP, Lemak NA,. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996; 35: 573-9.
2. Tokura Y, Heald PW, Yan SL, Edelson RL,. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. J Invest Dermatol 1992; 98: 33-7.
3. Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14: 282-9.
4. + T-cell phenotype. Am J Surg Pathol 2002; 26: 450-7.
5. Willemze R, Jaffe E, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.
6. Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 2005; 32: 647-74.
7. Ziesche E, Scheiermann P, Bachmann M, et al. Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo. Clin Exp Immunol 2009; 157: 370-6.
8. Miyagaki T, Sugaya M, Suga H, et al. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma. Clin Cancer Res 2011; 17: 7529-38.
9. Bingold TM, Ziesche E, Scheller B, et al. Interleukin-22 detected in patients with abdominal sepsis. Shock 2010; 34: 337-40.